CompletedPhase 2NCT01588964

IPHC in Patients With Platinum-sensitive Recurrent Ovarian Cancer

Studying Malignant epithelial tumor of ovary

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Catholic University of the Sacred Heart
Principal Investigator: Anna Fagotti, MD, PhD
Catholic University of Sacred Heart
Intervention: HIPEC(procedure)
Enrollment: 30 target
Eligibility: 18-65 years · FEMALE
Timeline: 2005 – 2011

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01588964 on ClinicalTrials.gov

Other trials for Malignant epithelial tumor of ovary

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE2NCT06268665
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
University of California, Davis
RECRUITINGNANCT05937620
Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and ICG in Patients With Epithelial Ovarian Cancer
Fundacion Clinic per a la Recerca Biomédica
RECRUITINGNANCT06061874
Ga68-FAPI-46 PET/CT for Preoperative Assessment of Peritoneal Carcinomatosis
Jules Bordet Institute
RECRUITINGNANCT05457595
Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies
CNAO National Center of Oncological Hadrontherapy
ACTIVE NOT RECRUITINGPHASE3NCT01376752
Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in Relapse Ovarian Cancer Treatment
UNICANCER

See all trials for Malignant epithelial tumor of ovary →

← Back to all trials